Cannabis and the brain is a hot topic. For much too long, the green, leafy plant was considered to be a catalyst for mental health problems, such as schizophrenia and psychosis.
Australia’s Export Control Amendment (Certificate of Narcotics Exports) Bill 2020 is to improve access to global markets for the nation’s medicinal cannabis and hemp industries.
The mother of a young girl who suffers from a rare form of epilepsy is calling for increased availability of medicinal cannabis on the NHS after revealing her daughter’s struggles without the drug during the Covid-19 lockdown.
Medical cannabis patients experience an increase in various measures of life quality, according to a recent cross-sectional study published in the Cannabis and Cannabinoids Research journal. The study assessed web-based survey responses from over 1200 participants in the USA between April 2016 and February 2018.
St. Louis-based BeLeaf Medical LLC opened its first cultivation center—and the first medical cannabis cultivation facility in Missouri—in Earth City last week, according to a Springfield News-Leader report.
Kansas lawmakers introduced a medical cannabis legalization bill June 3, according to a Business Insurance report.
The new strain, the only one in the cannabis market, is totally legal as it is free of psychoactive components and stands out for its big therapeutic potential in the treatment of illness as Crohn’s disease, colon cancer, glaucoma, Parkinson’s and Alzheimer’s, among others.
Last week, the Louisiana Senate approved a bill that will considerably expand the state’s medicinal cannabis program. The House of Representatives approved the bill which would allow doctors to recommend medical cannabis for any condition they believe is debilitating to their patient, rather than just a few serious illnesses approved by the current law.
n increasing number of patients with rheumatoid arthritis (RA) are using cannabis to treat their symptoms, although systematic studies regarding efficacy in RA are lacking. Within this review we will give an overview on the overall effects of cannabinoids in inflammation and why they might be useful in the treatment of RA.
Minnesota’s medical cannabis program is unique, in that it routinely collects patient-reported scores on symptoms. This article focuses on changes in symptom severity reported by patients with cancer during their first 4 months of program participation.